Second Department of Internal Medicine, Osaka Medical College, 2-7 Daigaku-machi, Takatsuki-shi, Osaka, 569-8686, Japan,
Dig Dis Sci. 2014 Aug;59(8):1917-24. doi: 10.1007/s10620-014-3100-z. Epub 2014 Mar 11.
No previous studies have compared cytology obtained under endoscopic transpapillary gallbladder drainage (ETGD) and EUS-guided fine needle aspiration (EUS-FNA) for thick-walled gallbladders.
The present study investigated the diagnostic yield of bile cytology under ETGD and EUS-FNA for gallbladder tumors.
A total of 69 patients were diagnosed as having gallbladder wall thickening. Among these patients, 28 patients were diagnosed by clinical follow-up, solely by imaging such as computed tomography or by histological examination of surgical specimens. The remaining 41 patients underwent ETGD and/or EUS-FNA. In these 41 patients, the clinical data collected included gender, age, diameter of gallbladder wall, site of gallbladder wall thickening, final diagnosis, adverse events, and diagnostic yield of ETGD and EUS-FNA.
Cyto-histological diagnosis with EUS-FNA was higher than that with ETGD, with a sensitivity of 100 versus 71%, specificity of 100 versus 94%, and accuracy of 100 versus 88%, respectively, in the two groups. In addition, the sampling adequacy of EUS-FNA was 100%. Adverse events were seen in five patients in the ETGD group (mild pancreatitis), although no adverse events were seen in the EUS-FNA group (P = 0.08).
Our results suggest that EUS-FNA can be safely performed for the diagnosis of gallbladder lesions. Further, this procedure may be the diagnostic method of choice over cytology of bile juice obtained via ETGD to obtain histological evidence of gallbladder cancer.
以前没有研究比较过经内镜经皮胆囊引流(ETGD)和超声内镜引导下细针抽吸(EUS-FNA)获取的厚壁胆囊细胞学。
本研究调查了 ETGD 和 EUS-FNA 对胆囊肿瘤的胆汁细胞学诊断率。
共有 69 例患者被诊断为胆囊壁增厚。其中 28 例患者通过临床随访、仅通过 CT 等影像学检查或手术标本的组织学检查进行诊断。其余 41 例患者接受了 ETGD 和/或 EUS-FNA。在这 41 例患者中,收集的临床数据包括性别、年龄、胆囊壁直径、胆囊壁增厚部位、最终诊断、不良事件以及 ETGD 和 EUS-FNA 的诊断率。
EUS-FNA 的细胞学-组织学诊断率高于 ETGD,其敏感性分别为 100%和 71%,特异性分别为 100%和 94%,准确性分别为 100%和 88%。此外,EUS-FNA 的采样充足率为 100%。ETGD 组有 5 例患者出现不良事件(轻度胰腺炎),而 EUS-FNA 组无不良事件(P = 0.08)。
我们的结果表明,EUS-FNA 可安全用于诊断胆囊病变。此外,与通过 ETGD 获取的胆汁细胞学相比,该方法可能是获取胆囊癌组织学证据的首选诊断方法。